Compare ARK Genomic Revolution ETF (ARKG) vs GoPro Inc (GPRO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs GoPro Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while GoPro Inc trades at $0.76 (market cap $131.96M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | GPRO | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $2.88 |
52-Week Low | $23.09 | $0.64 |
Market Cap | — | $131.96M |
Enterprise Value | — | $179.91M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
GoPro (GPRO) trades at $0.76, up 0.37% with neutral technical signals. The company faces severe financial distress with negative net income margins (-20.7%) and ROE (-236.05%), though valuation ratios appear low (P/E 4.56, P/S 0.2). Recent strategic review for potential sale and CEO's $20M financing provide near-term catalysts, but consecutive earnings misses and declining revenue ($652M in 2025) highlight operational challenges.
Outlook remains highly speculative with binary outcomes. The strategic sale process offers potential upside, but ongoing cash burn, negative equity, and competitive pressures present substantial downside risk. Analyst sentiment is mixed with 21% buy ratings, reflecting the company's precarious financial position and event-driven investment thesis.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →
